$6.16
0.132.16%
At Close: -
$6.18
0.020.32%
After Hours: 6:16 PM EDT
15 minutes delayed
C4 Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of C4 Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CCCC | C4 Therapeutics | -$0.73 | -$0.37 | — | — | $2.66M | $4.78M | — | — | 08/06/2024 | Get Alert |
CCCC | C4 Therapeutics | -$0.71 | -$0.35 | -$0.41 | -17.14% | $3.76M | $8.10M | $3.04M | -62.48% | 05/08/2024 | Get Alert |
CCCC | C4 Therapeutics | -$0.76 | -$0.68 | -$0.68 | 0.00% | $2.85M | $3.19M | $3.26M | 2.23% | 02/22/2024 | Get Alert |
CCCC | C4 Therapeutics | -$0.65 | -$0.66 | -$0.55 | 16.67% | $6.75M | $5.46M | $11.07M | 102.78% | 11/01/2023 | Get Alert |
CCCC | C4 Therapeutics | -$0.56 | -$0.69 | -$0.73 | -5.80% | $13.83M | $6.44M | $2.66M | -58.63% | 08/08/2023 | Get Alert |
CCCC | C4 Therapeutics | -$0.65 | -$0.75 | -$0.71 | 5.33% | $7.65M | $5.46M | $3.76M | -31.15% | 05/04/2023 | Get Alert |
CCCC | C4 Therapeutics | -$0.31 | -$0.74 | -$0.76 | -2.70% | $20.09M | $7.81M | $2.85M | -63.46% | 02/23/2023 | Get Alert |
CCCC | C4 Therapeutics | -$0.51 | -$0.67 | -$0.65 | 2.99% | $8.50M | $9.07M | $6.75M | -25.53% | 11/03/2022 | Get Alert |
CCCC | C4 Therapeutics | -$0.51 | -$0.69 | -$0.56 | 18.84% | $9.78M | $7.64M | $13.83M | 81.07% | 08/04/2022 | Get Alert |
CCCC | C4 Therapeutics | -$0.49 | -$0.58 | -$0.65 | -12.07% | $7.43M | $8.05M | $7.65M | -4.92% | 05/05/2022 | Get Alert |
CCCC | C4 Therapeutics | -$3.45 | -$0.58 | -$0.31 | 46.55% | $8.26M | $7.08M | $20.09M | 183.80% | 02/24/2022 | Get Alert |
CCCC | C4 Therapeutics | -$17.55 | -$0.59 | -$0.51 | 13.56% | $8.45M | $7.61M | $8.50M | 11.70% | 11/10/2021 | Get Alert |
CCCC | C4 Therapeutics | — | -$0.59 | -$0.51 | 13.56% | — | $6.02M | $9.78M | 62.48% | 08/11/2021 | Get Alert |
CCCC | C4 Therapeutics | — | -$0.69 | -$0.49 | 28.99% | $6.80M | — | $7.43M | — | 05/13/2021 | Get Alert |
CCCC | C4 Therapeutics | — | — | -$3.45 | — | — | — | $8.26M | — | 03/11/2021 | Get Alert |
CCCC | C4 Therapeutics | -$8.93 | — | -$17.55 | — | $5.36M | — | $8.45M | — | 11/12/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $-0.41 | $-0.35 | -17.1 % |
Dec 2023 | 2024-02-22 | $-0.68 | $-0.68 | 0.00 % |
Sep 2023 | 2023-11-01 | $-0.55 | $-0.66 | 16.7 % |
Jun 2023 | 2023-08-08 | $-0.73 | $-0.69 | -5.80 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $3.04M | $8.10M | -62.5 % |
Dec 2023 | 2024-02-22 | $3.26M | $3.19M | 2.23 % |
Sep 2023 | 2023-11-01 | $11.07M | $5.46M | 102.8 % |
Jun 2023 | 2023-08-08 | $2.66M | $6.44M | -58.6 % |
C4 Therapeutics (CCCC) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $-0.41, which missed the estimate of $-0.35.
The Actual Revenue was $3M, which missed the estimate of $8.1M.
Browse earnings estimates, EPS, and revenue on all stocks.